SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002179
Filing Date
2015-11-03
Accepted
2015-11-03 16:28:37
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20150930x10q.htm 10-Q 1348727
2 EX-31.1 rigl-20150930ex31124dff6.htm EX-31.1 18500
3 EX-31.2 rigl-20150930ex312c21f67.htm EX-31.2 18418
4 EX-32.1 rigl-20150930ex321b43825.htm EX-32.1 9879
  Complete submission text file 0001558370-15-002179.txt   4338158

Data Files

Seq Description Document Type Size
5 EX-101.INS rigl-20150930.xml EX-101.INS 858480
6 EX-101.SCH rigl-20150930.xsd EX-101.SCH 34094
7 EX-101.CAL rigl-20150930_cal.xml EX-101.CAL 35661
8 EX-101.DEF rigl-20150930_def.xml EX-101.DEF 92501
9 EX-101.LAB rigl-20150930_lab.xml EX-101.LAB 275882
10 EX-101.PRE rigl-20150930_pre.xml EX-101.PRE 192377
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 151194070
SIC: 2834 Pharmaceutical Preparations